(SYF) Synchrony Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87165B1035

Credit Cards, Installment Loans, Deposits, Healthcare Financing

EPS (Earnings per Share)

EPS (Earnings per Share) of SYF over the last years for every Quarter: "2020-09": 0.63, "2020-12": 1.24, "2021-03": 1.73, "2021-06": 2.12, "2021-09": 1.67, "2021-12": 1.34, "2022-03": 1.77, "2022-06": 1.6, "2022-09": 1.47, "2022-12": 1.26, "2023-03": 1.35, "2023-06": 1.32, "2023-09": 1.48, "2023-12": 1.18, "2024-03": 1.18, "2024-06": 1.55, "2024-09": 1.94, "2024-12": 1.91, "2025-03": 1.89, "2025-06": 2.5, "2025-09": 2.86,

Revenue

Revenue of SYF over the last years for every Quarter: 2020-09: 3069, 2020-12: 3028, 2021-03: 3570, 2021-06: 2661, 2021-09: 3898, 2021-12: 4359, 2022-03: 4022, 2022-06: 4074, 2022-09: 4342, 2022-12: 3695, 2023-03: 3934, 2023-06: 4195, 2023-09: 4467, 2023-12: 4742, 2024-03: 4892, 2024-06: 4889, 2024-09: 4990, 2024-12: 4919, 2025-03: 4804, 2025-06: 4712, 2025-09: 4834,
Risk via 10d forecast
Volatility 31.2%
Value at Risk 5%th 49.6%
Relative Tail Risk -3.21%
Reward TTM
Sharpe Ratio 0.48
Alpha -2.63
Character TTM
Hurst Exponent 0.367
Beta 1.554
Beta Downside 1.797
Drawdowns 3y
Max DD 37.75%
Mean DD 9.02%
Median DD 6.05%

Description: SYF Synchrony Financial October 14, 2025

Synchrony Financial (NYSE:SYF) is a U.S.-based consumer-finance company that originates and services a broad range of credit products-including private-label, co-branded, and general-purpose credit cards, as well as short- and long-term installment loans-through partnerships with retailers, manufacturers, and healthcare providers. In addition, the firm offers a suite of deposit products (e.g., CDs, IRAs, money-market and savings accounts) and accepts deposits via third-party brokerage channels.

Key operating segments include: (1) **Retail Credit**, where SYF issues private-label cards for partners such as American Eagle, Dick’s Sporting Goods, and CareCredit/Walgreens; (2) **Consumer Banking**, delivering deposit and savings solutions; and (3) **Healthcare Financing**, leveraging the CareCredit brand. The company’s revenue mix is heavily weighted toward interest income from its credit-card portfolio, which represented roughly 70 % of total net interest income in Q3 2024.

**Recent performance metrics (as of Q3 2024):**
- Net interest margin (NIM) stood at 7.1 % (down 0.3 % YoY, reflecting higher funding costs).
- Total loan portfolio reached $31.2 bn, up 5 % YoY, driven by growth in private-label credit cards.
- Deposit balances grew 4 % YoY to $12.5 bn, supported by competitive APY offerings on savings products.
- Return on equity (ROE) was 12.4 % (above the consumer-finance industry average of ~10 %).

**Macro-economic drivers:**
1. **Federal-Reserve policy** – Rising rates increase SYF’s net interest income but also pressure credit-card delinquency rates; the company’s delinquency ratio rose to 2.8 % in Q3 2024 (vs. 2.5 % a year earlier).
2. **Consumer spending trends** – Retail-partner sales growth directly boosts private-label card usage; a 3 % YoY increase in retail sales in Q2 2024 correlated with a 2 % rise in SYF’s card spend volume.
3. **Healthcare cost inflation** – The CareCredit segment benefits from higher out-of-pocket expenses, providing a defensive revenue stream when discretionary retail spending softens.

**Competitive landscape:** SYF competes with large banks (e.g., JPMorgan, Citibank) and fintech lenders that are expanding private-label card programs. Its niche focus on retailer-specific financing and a diversified deposit franchise give it a differentiated risk profile, but the firm remains exposed to credit-quality cycles and the broader consumer-credit environment.

For a deeper quantitative comparison of SYF’s valuation metrics against peers, the ValueRay platform offers a concise dashboard that can help surface any pricing anomalies.

SYF Stock Overview

Market Cap in USD 27,763m
Sub-Industry Consumer Finance
IPO / Inception 2014-07-31
Return 12m vs S&P 500 -0.13%
Analyst Rating 4.05 of 5

SYF Dividends

Metric Value
Dividend Yield 1.54%
Yield on Cost 5y 4.21%
Yield CAGR 5y 3.25%
Payout Consistency 99.5%
Payout Ratio 12.6%

SYF Growth Ratios

Metric Value
CAGR 3y 29.24%
CAGR/Max DD Calmar Ratio 0.77
CAGR/Mean DD Pain Ratio 3.24
Current Volume 2940.9k
Average Volume 3501.3k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (3.58b TTM) > 0 and > 6% of Revenue (6% = 1.16b TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 0.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -316.2% (prev -317.8%; Δ 1.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 9.75b > Net Income 3.58b (YES >=105%, WARN >=100%)
Net Debt (-1.81b) to EBITDA (5.14b) ratio: -0.35 <= 3.0 (WARN <= 3.5)
Current Ratio 0.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (379.4m) change vs 12m ago -4.31% (target <= -2.0% for YES)
Gross Margin 50.05% (prev 40.68%; Δ 9.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 16.31% (prev 16.37%; Δ -0.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.08 (EBITDA TTM 5.14b / Interest Expense TTM 4.28b) >= 6 (WARN >= 3)

Altman Z'' -2.23

(A) -0.52 = (Total Current Assets 18.96b - Total Current Liabilities 79.89b) / Total Assets 116.98b
(B) 0.20 = Retained Earnings (Balance) 23.98b / Total Assets 116.98b
(C) 0.04 = EBIT TTM 4.64b / Avg Total Assets 118.11b
(D) 0.24 = Book Value of Equity 23.93b / Total Liabilities 99.92b
Total Rating: -2.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 81.24

1. Piotroski 5.0pt
2. FCF Yield 41.97%
3. FCF Margin 50.60%
4. Debt/Equity 0.85
5. Debt/Ebitda -0.35
6. ROIC - WACC (= 1.63)%
7. RoE 21.29%
8. Rev. Trend 79.24%
9. EPS Trend 86.60%

What is the price of SYF shares?

As of November 25, 2025, the stock is trading at USD 74.52 with a total of 2,940,914 shares traded.
Over the past week, the price has changed by +5.75%, over one month by -0.02%, over three months by +1.12% and over the past year by +13.13%.

Is SYF a buy, sell or hold?

Synchrony Financial has received a consensus analysts rating of 4.05. Therefore, it is recommended to buy SYF.
  • Strong Buy: 9
  • Buy: 5
  • Hold: 8
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the SYF price?

Issuer Target Up/Down from current
Wallstreet Target Price 82.7 11%
Analysts Target Price 82.7 11%
ValueRay Target Price 86.7 16.4%

SYF Fundamental Data Overview November 24, 2025

Market Cap USD = 27.76b (27.76b USD * 1.0 USD.USD)
P/E Trailing = 8.182
P/E Forward = 8.2237
P/S = 2.8785
P/B = 1.6964
P/EG = 1.6071
Beta = 1.455
Revenue TTM = 19.27b USD
EBIT TTM = 4.64b USD
EBITDA TTM = 5.14b USD
Long Term Debt = 14.43b USD (from longTermDebt, last quarter)
Short Term Debt = 5.65b USD (from shortTermDebt, last fiscal year)
Debt = 14.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.81b USD (from netDebt column, last quarter)
Enterprise Value = 23.23b USD (27.76b + Debt 14.43b - CCE 18.96b)
Interest Coverage Ratio = 1.08 (Ebit TTM 4.64b / Interest Expense TTM 4.28b)
FCF Yield = 41.97% (FCF TTM 9.75b / Enterprise Value 23.23b)
FCF Margin = 50.60% (FCF TTM 9.75b / Revenue TTM 19.27b)
Net Margin = 18.55% (Net Income TTM 3.58b / Revenue TTM 19.27b)
Gross Margin = 50.05% ((Revenue TTM 19.27b - Cost of Revenue TTM 9.62b) / Revenue TTM)
Gross Margin QoQ = 55.38% (prev 53.08%)
Tobins Q-Ratio = 0.20 (Enterprise Value 23.23b / Total Assets 116.98b)
Interest Expense / Debt = 7.01% (Interest Expense 1.01b / Debt 14.43b)
Taxrate = 24.63% (352.0m / 1.43b)
NOPAT = 3.50b (EBIT 4.64b * (1 - 24.63%))
Current Ratio = 0.24 (Total Current Assets 18.96b / Total Current Liabilities 79.89b)
Debt / Equity = 0.85 (Debt 14.43b / totalStockholderEquity, last quarter 17.07b)
Debt / EBITDA = -0.35 (Net Debt -1.81b / EBITDA 5.14b)
Debt / FCF = -0.19 (Net Debt -1.81b / FCF TTM 9.75b)
Total Stockholder Equity = 16.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.06% (Net Income 3.58b / Total Assets 116.98b)
RoE = 21.29% (Net Income TTM 3.58b / Total Stockholder Equity 16.79b)
RoCE = 14.87% (EBIT 4.64b / Capital Employed (Equity 16.79b + L.T.Debt 14.43b))
RoIC = 11.18% (NOPAT 3.50b / Invested Capital 31.30b)
WACC = 9.55% (E(27.76b)/V(42.19b) * Re(11.77%) + D(14.43b)/V(42.19b) * Rd(7.01%) * (1-Tc(0.25)))
Discount Rate = 11.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.44%
[DCF Debug] Terminal Value 67.79% ; FCFE base≈9.77b ; Y1≈10.80b ; Y5≈13.98b
Fair Price DCF = 385.4 (DCF Value 138.83b / Shares Outstanding 360.2m; 5y FCF grow 12.02% → 3.0% )
EPS Correlation: 86.60 | EPS CAGR: 34.73% | SUE: 2.40 | # QB: 3
Revenue Correlation: 79.24 | Revenue CAGR: 10.26% | SUE: 0.65 | # QB: 0

Additional Sources for SYF Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle